VEGF is a mediator of IBD by promoting intestinal angiogenesis and inflammation and it also can promote pulmonary angiogenesis, leukocyte extravasation, inflammation, and decreased endothelial barrier function in the lungs. Here, VEGFA is linked to inflammatory bowel disease.